These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 14506587)

  • 1. Safety of a modified-live combination vaccine against respiratory and reproductive diseases in pregnant cows.
    Ellsworth MA; Brown MJ; Fergen BJ; Ficken MD; Tucker CM; Bierman P; TerHune TN
    Vet Ther; 2003; 4(2):120-7. PubMed ID: 14506587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle.
    Talens LT; Beckenhauer WH; Thurber ET; Cooley AJ; Schultz RD
    J Am Vet Med Assoc; 1989 May; 194(9):1273-80. PubMed ID: 2542202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
    Cravens RL; Ellsworth MA; Sorensen CD; White AK
    J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.
    Fulton RW; Confer AW; Burge LJ; Perino LJ; d'Offay JM; Payton ME; Mock RE
    Vaccine; 1995; 13(8):725-33. PubMed ID: 7483787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W; Mattick D; Smith L
    Vaccine; 2011 Jun; 29(29-30):4657-62. PubMed ID: 21596076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive safety of vaccination with Vista 5 L5 SQ near breeding time as determined by the effect on conception rates.
    Bolton M; Brister D; Burdett B; Newcomb H; Nordstrom S; Sanders B; Shelton T
    Vet Ther; 2007; 8(3):177-82. PubMed ID: 17926303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
    Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bovine herpesvirus-1 inactivated vaccine against abortion and stillbirth in pregnant heifers.
    Zimmerman AD; Buterbaugh RE; Herbert JM; Hass JM; Frank NE; Luempert Iii LG; Chase CC
    J Am Vet Med Assoc; 2007 Nov; 231(9):1386-9. PubMed ID: 17976001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk production and reproductive performance in dairy cows given bovine respiratory syncytial virus vaccine prior to parturition.
    Ferguson JD; Galligan DT; Cortese V
    J Am Vet Med Assoc; 1997 Jun; 210(12):1779-83. PubMed ID: 9187730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.